Adherence Assessment With Travalert Dosing Aid

PHASE4CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Open-angle GlaucomaOcular Hypertension
Interventions
DRUG

Travoprost 0.004%/timolol 0.5% fixed combination eye drops (DuoTrav)

One drop in the study eye once daily at 9 p.m. for six months using the Travalert device.

DRUG

Travoprost 0.004% eye drops

One drop in the study eye once daily at 9 p.m. for six months using the Travalert device.

DRUG

Timolol 0.05% eye drops

One drop in the study eye twice daily at 9 a.m. and 9 p.m. for six months using the Travalert device.

DEVICE

Travalert Dosing Aid

Approved device used with study medication to record time of instillation and quantify dosing

Trial Locations (1)

50009

Zaragoza, Zaragoza

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alcon Research

INDUSTRY